SCHEMBL6022145

SCHEMBL6022145

Cn1c(=O)cc(C(F)(F)F)c2cc(S(=O)(=O)Nc3ccc4c(c3)OCO4)ccc21

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 7/20 0.68
ALDH1A1 P00352 5/20 0.68
TAS2R14 Q9NYV8 3/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
HTT P42858 3/20 0.68
MAPT P10636 7/20 0.61
USP2 O75604 2/20 0.61
GLA P06280 1/20 0.61
RAB9A P51151 1/20 0.61
HPGD P15428 4/20 0.56
TSHR P16473 2/20 0.56
GFER P55789 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 2/20 0.53
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
TP53 P04637 2/20 0.49
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022407 0.82 KMT2A (0.59) PKMTAS2R14SMN1; SMN2HTTMAPT
SCHEMBL1616041 0.81 PKM (1.00) PKMALDH1A1TAS2R14SMN1; SMN2HTT
SCHEMBL6022493 0.81 BRD1 (0.61) PKMALDH1A1TAS2R14SMN1; SMN2HTT
SCHEMBL6022431 0.81 BRD1 (0.61) PKMTAS2R14SMN1; SMN2HTTMAPT
SCHEMBL6022109 0.79 PKM (0.53) PKMALDH1A1SMN1; SMN2HTTMAPT
SCHEMBL6022696 0.79 GFER (0.55) PKMALDH1A1TAS2R14SMN1; SMN2HTT
SCHEMBL6022498 0.78 PKM (0.60) PKMALDH1A1SMN1; SMN2HTTMAPT
SCHEMBL17560715 0.76 BRPF1 (0.75) PKMSMN1; SMN2MAPTTP53
SCHEMBL7542214 0.76 PKM (1.00) PKMALDH1A1TAS2R14SMN1; SMN2HTT
SCHEMBL1616042 0.75 TAS2R14 (1.00) PKMALDH1A1TAS2R14SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7009052-B2 Sulfonamide derivatives WARNER LAMBERT COMPANY LLC (US) 2006-03-07 US claimed
US-20050004367-A1 Sulfonamide derivatives DU DANIEL Y (US) 2005-01-06 US claimed
US-7009052-B2 Sulfonamide derivatives WARNER LAMBERT COMPANY LLC (US) 2006-03-07 US disclosed
US-20050004367-A1 Sulfonamide derivatives DU DANIEL Y (US) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004367-A1 Sulfonamide derivatives AR, SULT2A1, SHBG PKM 3741/4885ALDH1A1 841/4885TAS2R14 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.